期刊文献+

经尿道前列腺钬激光剜除术联合膀胱小切口与经尿道双极等离子前列腺剜除术治疗高危大体积前列腺增生的比较研究 被引量:35

Comparative study of Holep combined treatment of bladder small incision and PKERP for high-risk large volume prostate hyperplasia
下载PDF
导出
摘要 目的比较经尿道前列腺钬激光剜除术(Holep)联合膀胱小切口与经尿道双极等离子前列腺剜除术(PKERP)两种方法治疗高危大体积良性前列腺增生(BPH)的安全性及有效性。方法分析Holep联合膀胱小切口治疗高危大体积BPH患者110例与采用PKERP术治疗高危大体积BPH患者108例临床资料,对两组的手术时间、术中出血量、电切综合征(TURS)、术后冲洗时间、留置导尿时间、术后国际前列腺症状评分(IPSS)和生活质量指数(QOL)评分、最大尿流率(Qmax)、膀胱残余尿量(PVR)、术后尿道狭窄和尿路刺激症进行比较。结果两组患者术前一般资料差异无统计学意义(P>0.05),术后IPSS、QOL、Qmax、PVR与术前比较均有统计学意义(P<0.01),但两组间比较差异无统计学意义(P>0.05);手术时间及术中出血量Holep组明显小于PKERP组,术后冲洗时间、留置导尿时间、TURS、尿道狭窄和尿路刺激征两组比较差异无统计学意义。结论Holep联合膀胱小切口与PKERP均是高危大体积良性前列腺增生的有效手术方法,但Holep联合膀胱小切口术中出血量少,手术时间短,对于高危大体积BPH患者安全性更高。 【Objective】To assess the clinical efficacy and safety of the treatment about Holep joint bladder small incision and PKERP for large volume of high-risk benign prostatic hyperplasia.【Methods】The surgical procedures of 110 cases with Holep joint bladder small incision and 108 cases with PKERP. The operative time, blood loss,transurethral resection syndrome(TURS), washing time after surgery, catheterization time, international prostate symptom score(IPSS), quality of life(QOL), maximun flow rate(Qmax), post void residua(PVR) and postoperative urethral stricture, urinary tract irritation comparison were compared.【Results】The were no significant differences of preoperative factors between two groups(P〉0.05), the IPSS, QOL, Qmax, PVR before and after surgery were significant differences(P〈0.01), but no significant between the two groups difference(P〈0.05); operative time and blood loss was significantly less than PKERP, washing time after surgery, catheterization time, TURS, urethral stricture and urinary tract irritation was no significant difference between the two groups. 【Conclusions】The two surgical are effective to the treatment of benign prostatic hyperplasia, but Holep joint bladder small incision is higher security in less blood loss, shorter operative time for large volume of high-risk BPH patients.
出处 《中国内镜杂志》 北大核心 2015年第10期1028-1032,共5页 China Journal of Endoscopy
关键词 前列腺增生 前列腺钬激光剜除 膀胱小切口 前列腺等离子剜除 prostatic hyperplasia holmium laser enucleation of the prostate bladder small incision plasma prostate enucleation
  • 相关文献

参考文献11

  • 1王鑫,王建业,刘明,于普林,张传芳,孙振球,张亚群,汪洪海.中国11城市老年科门诊良性前列腺增生患者药物治疗的现状及分析[J].中华老年医学杂志,2010,29(3):246-249. 被引量:7
  • 2FERRETTI S, AZZOLINI N, BARBIERI A, et al. Randomized-comparison of loops for transurethral resection of the prostate:preliminary result[J]. J Endourol, 2004,18(9): 897-900.
  • 3KALLENBERG F, HOSSACK TA, WOO HH. Long-term followup after electrocautery transurethral resection of the prostate forbenign prostatic hyperplasia[J]. Adv Urol, 2011,22(3): 359-478.
  • 4UU C, .ZHENG S, LI H, et al. Transurethral enucleation andresection of prostate in patients with benign prostatic hyperplasiaby plasma Kinetics[J]. J Urol, 2010, 184(6): 2440-2445.
  • 5SINANOGLU 0,EKICI S,TATAR MN, et al. Postoperative out-comes of plasmakinetic transurethral resection of the prostate incompared to monopolar transurethral resection of the prostate inpatients with comorbidities[J]. Urology, 2012,80(2): 402-406.
  • 6VAN RU S, GILLING PJ. In 2013,holmium laser enucleation ofthe prostate (HoLEP) may be the new 'gold standard' [J]. CurrUrol Rep, 2012, 13(6): 427-432.
  • 7廖晓星,侯垒,崔功静,胡彬,史复,孙庭.经尿道选择性电切治疗高危前列腺增生与传统电切比较[J].中华临床医师杂志(电子版),2012,6(5):153-155. 被引量:13
  • 8杜传军,白福鼎,陈继民,裘益青,经霄,罗尉,顾才校.前列腺钬激光剜出术与电切术安全性及疗效比较[J].中华泌尿外科杂志,2004,25(9):627-630. 被引量:42
  • 9BAGLEY DH. Endourologic use of the holnium laser[J]. TetonNew Media, 2001, 12(2): 1-68.
  • 10刘齐贵,李新,麻伟青,邝丽新,张文滔,窦坤,姚建中,曹伟,周庆余,王跃力,段娟.经尿道钬激光前列腺剜除术治疗症状性前列腺增生症3162例分析[J].中华外科杂志,2013,51(2):123-126. 被引量:50

二级参考文献47

  • 1安尼瓦尔.牙生,宋光鲁,李建兴,王玉杰.气压弹道联合超声碎石术和经尿道前列腺汽化电切术治疗良性前列腺增生合并膀胱结石[J].中国微创外科杂志,2008,8(4):323-324. 被引量:19
  • 2孔建业,刘东彪,魏勇,陈刚.膀胱碎石器加气压弹道碎石治疗膀胱及尿道结石[J].实用医药杂志,2005,22(11):995-995. 被引量:7
  • 3Welch G,Weinger K,Barry MJ.Quality of life impact of lower urinary tract symptom severity:results from the health professionals follow-up study.Urology,2002,59:245-250.
  • 4Tinel H,Stelte-Ludwig B,Hutter J,et al.Preclinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.BJU International,2006,98:259-263.
  • 5Djavan B,Marberger M.Meta-analysis on th e efficacy and tolerability of alphal-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benignprostatic obstruction.Eur Urol,1999,36:1-13.
  • 6McConnell JD,Bruskewitz R,Walsh P,et al.The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia N Engl J Med,1998,338:557-563.
  • 7Roehrborn CG.The potential of serum prostatespecific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia.BJU Int,2004,93:21-26.
  • 8Crawford ED,Wilson SS,McConnell JD,et al.Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.J Urol,2006,175:1422-1427.
  • 9Kaplan SA,McConnell JD,Roehrborn CG,et al.Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25ml or greater.J Urol,2006,175:217-221.
  • 10McConnell JD,Roehrborn CG,Bautista OM,et al.The long term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349:2387-2398.

共引文献129

同被引文献254

引证文献35

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部